TICKERNOMICS Sign up
Last Update: 2024-03-28 02:12:16
PetIQ Inc. ( PETQ ) https://petiq.com
17.79USD
Sector:
Healthcare
Industry:
Drug Manufacturers-Specialty & Generic
Country:
United States
1y
3y
5y
10y
Historical Returns*:
SPY
31.15%
PETQ
47.88%
SPY
32.74%
-48.48%
PETQ
SPY
92.93%
-43.36%
PETQ
SPY
224.41%
PETQ
0.00%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
522.98
851.84
0.26
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
41.08
0.49
2.19
20.20
0.00
7.87
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
3.38
26.21
9.34
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
11.4689
7.08
5.60
1.93
Other Earnings and Cash Flow Stats:
PetIQ Inc. ( PETQ ) Net Income TTM ($MM) is -46.31
PetIQ Inc. ( PETQ ) Operating Income TTM ($MM) is 25.63
PetIQ Inc. ( PETQ ) Owners' Earnings Annual ($MM) is 108.86
PetIQ Inc. ( PETQ ) Current Price to Owners' Earnings ratio is 5.41
PetIQ Inc. ( PETQ ) EBITDA TTM ($MM) is 67.95
PetIQ Inc. ( PETQ ) EBITDA Margin is 9.34%
Capital Allocation:
PetIQ Inc. ( PETQ ) has paid 0.00 dividends per share and bought back -0.556 million shares in the past 12 months
PetIQ Inc. ( PETQ ) has reduced its debt by 42.053 million USD in the last 12 months
Capital Structure:
PetIQ Inc. ( PETQ ) Interest-bearing Debt ($MM) as of last quarter is 445
PetIQ Inc. ( PETQ ) Annual Working Capital Investments ($MM) are 5
PetIQ Inc. ( PETQ ) Book Value ($MM) as of last quarter is 239
PetIQ Inc. ( PETQ ) Debt/Capital as of last quarter is 201%
Other Balance Sheet Stats:
PetIQ Inc. ( PETQ ) has 116 million in cash on hand as of last quarter
PetIQ Inc. ( PETQ ) has 189 million of liabilities due within 12 months, and long term debt 445 as of last quarter
PetIQ Inc. ( PETQ ) has 29 common shares outstanding as of last quarter
PetIQ Inc. ( PETQ ) has 0 million USD of preferred stock value
Academic Scores:
PetIQ Inc. ( PETQ ) Altman Z-Score is 2.13 as of last quarter
PetIQ Inc. ( PETQ ) Piotroski Score is 7.00 as of last quarter
Corporate Governance:
PetIQ Inc. ( PETQ ) largest shareholder is owning shares at 0.00 ($MM) value
Allan Hall(an insider) Bought 600 shares of PetIQ Inc. ( PETQ ) for the amount of $9048.00 on 2022-06-14
6.68% of PetIQ Inc. ( PETQ ) is held by insiders, and 93.67% is held by institutions
PetIQ Inc. ( PETQ ) went public on 2017-07-21
Other PetIQ Inc. ( PETQ ) financial metrics:
FCF:112.74
Unlevered Free Cash Flow:95.81
EPS:0.06
Operating Margin:3.38
Gross Profit Margin:26.21
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:0.76
Beta:1.93
Buffet's Owners Earnings:108.86
Price to Owner's Earnings:5.41
About PetIQ Inc. ( PETQ ) :
PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which include flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and develops and manufactures its own proprietary value-branded products, as well as distributes third-party branded medications. It also provides OTC medications and supplies primarily within the flea and tick control, and behavior management categories of the health and wellness industry in various forms, such as spot on (topical) treatments, chewables, oral tablets, and collars. In addition, the company offers health and wellness products that include dental treats and nutritional supplements, which comprise hip and joint, vitamins, and skin and coat products. The company provides its products primarily under the PetIQ, PetArmor, VIP Petcare, VetIQ PetCare, VetIQ, Capstar, Advecta, SENTRY, Sergeants, PetLock, Heart Shield Plus, TruProfen, Betsy Farms, PetAction, Minties, Vera, and Delightibles brands. In addition, the company offers a suite of services at community clinics and wellness centers hosted at pet retailers, including diagnostic tests, vaccinations, preion medications, microchipping, and wellness checks. It operates through veterinarian, retail, and e-commerce channels. The company was founded in 2010 and is headquartered in Eagle, Idaho.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.